Guidance for Clinical Investigators, Industry, and FDA Staff1: Financial Disclosure by Clinical Investigators

摘要

This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if theapproach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call theappropriate number listed on the title page of this guidance.